Revenue growth of 25%, significant margin improvement and strong balance sheet
MISSISSAUGA, ON, Feb. 23, 2023 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its first quarter fiscal 2023 results for the period ended December 31, 2022.
Read more at prnewswire.com